25 May 2013
Keywords: Merck & Co, Johnson & Johnson, McNeil, Consumer, OTC joint venture, USA, Canada
Article | 29 September 2011
US drug giant Merck & Co (NYSE: MRK) said yesterday that it has sold its 50% interest in the Johnson & ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2011
28 September 2011
24 May 2013
© 2013 thepharmaletter.com